BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11861389)

  • 1. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
    Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
    Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma.
    Liu H; Jacobs BS; Liu J; Prayson RA; Estes ML; Barnett GH; Barna BP
    Cancer Immunol Immunother; 2000 Aug; 49(6):319-24. PubMed ID: 10946814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
    Antoniu SA
    Curr Opin Investig Drugs; 2010 Nov; 11(11):1286-94. PubMed ID: 21157648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
    Rahaman SO; Vogelbaum MA; Haque SJ
    Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis.
    Fichtner-Feigl S; Strober W; Kawakami K; Puri RK; Kitani A
    Nat Med; 2006 Jan; 12(1):99-106. PubMed ID: 16327802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.
    Fujisawa T; Joshi BH; Puri RK
    Int J Cancer; 2012 Jul; 131(2):344-56. PubMed ID: 21858811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.
    Han J; Yang L; Puri RK
    J Neurooncol; 2005 Mar; 72(1):35-46. PubMed ID: 15803373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
    Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
    J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas.
    Li X; Xiao X; Wang Y; Gu G; Li T; Wang Y; Li C; Zhang P; Ji N; Zhang Y; Zhang L
    Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex.
    Tollenaere MAX; Mølck C; Henderson I; Pollack S; Addis P; Petersen HH; Norsgaard H
    JID Innov; 2023 Sep; 3(5):100214. PubMed ID: 37554517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAR-NK cell therapy for glioblastoma: what to do next?
    Xiong Q; Zhu J; Zhang Y; Deng H
    Front Oncol; 2023; 13():1192128. PubMed ID: 37404752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide.
    Jannoo R; Walker W; Kanamarlapudi V
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Fibroblasts in Chronic Inflammatory Signalling in Chronic Rhinosinusitis with Nasal Polyps-A Systematic Review.
    Palacios-García J; Porras-González C; Moreno-Luna R; Maza-Solano J; Polo-Padillo J; Muñoz-Bravo JL; Sánchez-Gómez S
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate lymphoid cells in depression: Current status and perspectives.
    Madeshiya AK; Pillai A
    Biomark Neuropsychiatry; 2022 Dec; 7():. PubMed ID: 37123464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide.
    Jannoo R; Xia Z; Row PE; Kanamarlapudi V
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis.
    Liu Z; Zhang L; Liang Y; Lu L
    Front Cell Infect Microbiol; 2022; 12():1035765. PubMed ID: 36389166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 4/13 signaling in cardiac regeneration and repair.
    Bakhshian Nik A; Alvarez-Argote S; O'Meara CC
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H833-H844. PubMed ID: 36149768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.
    Shankar A; McAlees JW; Lewkowich IP
    J Allergy Clin Immunol; 2022 Aug; 150(2):266-276. PubMed ID: 35934680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma.
    Rechberger JS; Porath KA; Zhang L; Nesvick CL; Schrecengost RS; Sarkaria JN; Daniels DJ
    Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy.
    Muhammad N; Wang R; Li W; Zhang Z; Chang Y; Hu Y; Zhao J; Zheng X; Mao Q; Xia H
    Mol Ther Oncolytics; 2022 Mar; 24():729-741. PubMed ID: 35317513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.